已收盤 09-20 16:00:00 美东时间
-0.021
-2.94%
NanoVibronix press release (NASDAQ:NAOV): Q2 Revenue of $0.82M. The loss from operations was reduced by more than 30% to approximately ($674,000) compared to the quarter ended June 30, 2023. Reported...
08-21 22:56
NanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced
05-22 20:36
Nanovibronix Announces Commencement of Uroshield Clinical Study at the Universi...
05-22 20:30
The latest update is out from NanoVibronix Inc (NAOV). NanoVibronix, Inc. has s...
05-17 04:27
NanoVibronix(NAOV.US):2024年Q1财报实现营收92.1万美元,前值为35.4万美元;每股收益为-0.23美元,前值为-0.67美元。
05-16 07:31
NanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix," or the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic
05-14 20:50
An update from NanoVibronix Inc (NAOV) is now available. NanoVibronix, Inc. rec...
04-10 04:24
We are committed to our strategic vision of developing, improving and commercializing our distinct and effective therapies, which we believe enable healthcare providers to treat patients in need, fill a void in the
04-09 20:55